Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v1-EN
Language French English
Date Updated 2021-08-18 2021-08-18
Drug Identification Number 02261901 02261901
Brand name SANDOZ-DICLOFENAC SR SANDOZ-DICLOFENAC SR
Common or Proper name SANDOZ-DICLOFENAC SR SANDOZ-DICLOFENAC SR
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients DICLOFENAC SODIUM DICLOFENAC SODIUM
Strength(s) 75MG 75MG
Dosage form(s) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100PRT BO V1 CA 100PRT BO V1 CA
ATC code M01AB M01AB
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2021-08-12 2021-08-12
Remaining supply date 2021-08-12 2021-08-12
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments